Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 19603154)

1.

Seretide withdrawal increases airway inflammation in moderate COPD patients.

Borrill Z, Roy K, Kolsum U, Southworth T, Vestbo J, Singh D.

Eur J Clin Pharmacol. 2009 Nov;65(11):1165-6. doi: 10.1007/s00228-009-0697-5. Epub 2009 Jul 15. No abstract available.

PMID:
19603154
2.

[Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].

Vestbo J.

Ugeskr Laeger. 2004 Jan 19;166(4):271-4. Danish. No abstract available.

PMID:
14964108
4.
5.

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J.

Respir Res. 2009 Jun 30;10:59. doi: 10.1186/1465-9921-10-59.

6.

COPD: treatments benefit patients.

Rennard SI.

Lancet. 2003 Feb 8;361(9356):444-5. No abstract available.

PMID:
12583937
7.

Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).

[No authors listed]

Med Lett Drugs Ther. 2010 May 31;52(1339):41-2. No abstract available.

PMID:
20508579
8.

Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial.

Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group.

Ann Intern Med. 2009 Oct 20;151(8):517-27.

PMID:
19841453
9.

Differentiating asthma and COPD patients.

El-Kassimi FA.

Chest. 2004 Aug;126(2):653-4; author reply 654-5. No abstract available.

PMID:
15302761
10.

Prevention of death in COPD.

Kupfer Y, Tessler S.

N Engl J Med. 2007 May 24;356(21):2212-3; author reply 2213-4. No abstract available.

PMID:
17526086
11.

[Impact of COPD therapy on patient survival: the TORCH Study (TOwards a Revolution in COPD Health)].

Nitschmann S, Schultze-Werninghaus G.

Internist (Berl). 2007 Dec;48(12):1450-2. German. No abstract available.

PMID:
17965844
12.

Fluticasone/salmeterol: labeling change.

[No authors listed]

Prescrire Int. 2008 Dec;17(98):229.

PMID:
19418648
13.

[Beta mimetic drug plus steroid. Powerful duo also in COPD].

[No authors listed]

MMW Fortschr Med. 2002 Aug 22;144(33-34):53. German. No abstract available.

PMID:
12380146
14.

Prevention of death in COPD.

Duerden M.

N Engl J Med. 2007 May 24;356(21):2212; author reply 2213-4. No abstract available.

PMID:
17526087
15.

Seretide: a pharmacoeconomic analysis.

Fritscher L, Chapman KR.

J Med Econ. 2008;11(3):555-70. doi: 10.3111/13696990802320908. Review.

PMID:
19450105
16.

Bronchodilation in COPD: beyond FEV1-the effect of albuterol on resistive and reactive properties of the respiratory system.

Costa GM, Faria AC, Di Mango AM, Lopes AJ, Jansen JM, Melo PL.

J Bras Pneumol. 2009 Apr;35(4):325-33. English, Portuguese.

17.

Prevention of death in COPD.

La Vecchia C, Fabbri LM.

N Engl J Med. 2007 May 24;356(21):2211-2; author reply 2213-4. No abstract available.

PMID:
17526088
18.

Assessing mortality risk in COPD.

Richie RC.

J Insur Med. 2008;40(1):55-63. No abstract available.

PMID:
18924368
19.

[Chronic obstructive pulmonary disease. No increased survival with combination therapy].

Ecker-Schlipf B.

Med Monatsschr Pharm. 2007 Nov;30(11):428-9. German. No abstract available.

PMID:
18062342
20.

Beta-blocker use in patients with COPD.

Dachs R, Anugwom C.

Am Fam Physician. 2006 Dec 1;74(11):1858. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk